Aspirin/Simvastatin

阿司匹林/辛伐他汀

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Simvastatin
Drug Alias NameSimvastatin/Acetylsalicylic Acid辛伐他汀+阿司匹林辛伐他汀/阿司匹林Simvastatin+Acetylsalicylic AcidAcetylsalicylic Acid/Simvastatin +[12] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitors
TargetsHMG-CoA reductaseCyclooxygenases
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AspirinSimvastatin
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoryung Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A